[Endophthalmitis after repeated bevacizumab injections].
Symptoms resembling endophthalmitis developed 1 day after the seventh injection of bevacizumab in a 76-year-old woman with extrafoveal occult choroidal neovascularization in conjunction with age-related macular degeneration. The diagnosis reached was an immune reaction with pseudohypopyon after repeated bevacizumab injections. The condition resolved completely within 5 days under sole administration of corticosteroids. Treatment was then continued with pegaptanib and no further intraocular irritation occurred.
Schaal
K B
KB
Schwerpunkt Retinologie, Universitäts-Augenklinik, Heidelberg, Deutschland.
Höh
A E
AE
Scheuerle
A
A
Dithmar
S
S
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D009877:Endophthalmitis / Q000139:chemically induced* / Q000188:drug therapy*; D005260:Female; D006801:Humans
D000305:Adrenal Cortex Hormones; D020533:Angiogenesis Inhibitors; D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab
Retina. 2003 Oct;23(5):686-91
14574256
Ophthalmology. 2005 Jun;112(6):1048-53
15885778
Ophthalmologe. 2004 Feb;101(2):121-8
14991307
Ophthalmic Surg Lasers Imaging. 2005 Jan-Feb;36(1):24-9
15688968
Graefes Arch Clin Exp Ophthalmol. 2008 May;246(5):779-81
18204851